Monthly dividend REITs remain relevant in September 2026 because they combine a visible income cadence with ownership of income-producing real estate. Investors are still weighing higher interest rates against the appeal of recurring distributions, but the sector’s case is no longer based only on its bond-proxy reputation. Disciplined balance sheets, limited supply in several property markets and secular demand in areas such as data centers, senior housing and health care are making property-level fundamentals increasingly important.
The opportunity set is broad. Equity REITs with durable rent growth, residential landlords, health care and senior-housing operators offer different versions of defensive real-estate exposure, while mortgage REITs can provide much higher income potential with greater sensitivity to rates, financing and credit conditions. A July 2026 mid-year update from Nareit said REITs had rebounded strongly and were positioned for further gains after outperforming the broad equity market through mid-year, reinforcing the importance of fundamentals alongside yield.
This seven-stock countdown covers a range of business models, from health care facilities and industrial properties to experiential real estate, Manhattan offices and government-backed residential mortgage securities. The picks are presented in countdown order from #7 to #1, with the strongest overall fit for the monthly dividend REIT theme reserved for the final entry.
Our screen is limited to U.S.-listed REITs with market capitalizations above $500 million and uses primary-source financial data, operating metrics, valuation measures, earnings history and composite quality grades. The ranking first emphasizes depth of exposure to the monthly dividend REIT theme and then considers business fundamentals, including profitability, growth, valuation and earnings consistency. This is a countdown: #7 appears first, while the best pick is revealed at #1.
What they do. The company is a self-administered, self-managed health care REIT that owns and invests in real estate serving the health care industry across the United States and Canada. Its specialized property focus gives investors direct exposure to health care facilities rather than a broad collection of unrelated real-estate categories.
Why it fits. Sabra fits the theme through its concentrated health care real-estate exposure, one of the property types highlighted in the broader income REIT opportunity. The model is tied to real estate serving health care demand, giving the stock a more defensive operating narrative than a purely discretionary property portfolio, although the company remains exposed to tenant and operator conditions.
Numbers that matter. Revenue growth was 25.3% year over year, but earnings growth was negative 5.6%. Sabra posted a 50.3% gross margin and a 7.58% net margin, while return on equity was only 2.39%. The trailing P/E ratio was 75.92 and the forward P/E ratio was 32.15, leaving valuation demanding relative to the company’s modest profitability.
Recent momentum. In the August 3 quarter, EPS was $0.40 versus a $0.38 estimate, a 5.3% beat, but the company has beaten estimates in only 3 of the last 7 reported quarters. Analysts show 1 Buy and 7 Holds, with an average target of $22.7857 and a consensus score of 3.8462, suggesting interest in the health care exposure without a strong consensus on execution.
What they do. Healthpeak is a fully integrated REIT that owns, operates and develops real estate for health care discovery and delivery. Its scale and integrated structure provide exposure to specialized health care properties through ownership, operations and development rather than through a single facility type.
Why it fits. The company is a direct match for the health care portion of the monthly dividend REIT theme, with properties designed around both discovery and delivery. That focus places it in a property segment supported by long-term health care needs, while its development activity adds a growth dimension that is not present in a simple portfolio of stabilized buildings.
Numbers that matter. Revenue increased 11.1% year over year and earnings growth was 68.2%. Healthpeak reported a 57.6% gross margin, a 15.99% operating margin and an 8.25% net margin, with return on equity of 3.04%. The trailing P/E was 58.09, while the forward P/E was 169.49 against trailing EPS of $0.35 and next-year EPS estimates of $0.14, making forward earnings a key valuation concern.
Recent momentum. Healthpeak’s August 4 quarter produced EPS of $0.46 versus an estimate of $0.44, a 4.5% beat, and the company has beaten estimates in 4 of the last 7 quarters. The analyst breakdown is evenly split between 5 Buys and 5 Holds; the consensus score is 4.25 and the average target is $23, indicating constructive sentiment despite the valuation and earnings-estimate uncertainty.
What they do.STAG focuses on acquiring, developing, owning and operating industrial properties throughout the United States. As of June 30, 2026, its portfolio contained 606 buildings in 41 states and approximately 122.6 million rentable square feet, giving the company meaningful scale within the industrial REIT category.
Why it fits. Industrial real estate is one of the clearest ways to access the sector’s newer property mix and secular demand story. STAG’s focus on a large, geographically distributed industrial portfolio makes it relevant to investors seeking an equity REIT with exposure beyond traditional offices and retail, though the business remains tied to industrial occupancy and leasing conditions.
Numbers that matter. Revenue growth was 8.1% year over year and earnings growth was 3.3%. STAG produced a 79.5% gross margin, a 37.04% operating margin and a 28.05% net margin, while return on equity was 6.98% and return on assets was 2.89%. The trailing P/E was 28.92, but the forward P/E was 144.93, signaling that current earnings and valuation expectations deserve close attention.
Recent momentum.STAG’s July 28 quarter matched estimates at $0.65 of EPS, while its seven-quarter record shows 5 beats. Analysts list 2 Buys and 7 Holds, with a consensus score of 3.6667 and an average target of $41.8333. That combination points to a solid operating profile but a market that remains measured about the next stage of earnings growth.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
What they do.EPR is a diversified experiential net lease REIT specializing in properties that support out-of-home leisure and recreation. Its portfolio spans 43 states and Canada, with approximately $6.1 billion of total assets after accumulated depreciation, and its investment approach centers on property and tenant-level cash-flow standards.
Why it fits.EPR brings specialized real estate exposure to the list through experiential venues rather than health care, industrial or office assets. That makes it a differentiated income-oriented REIT, but its concentration in leisure and recreation also means the cash-flow story is more connected to discretionary consumer spending than the defensive segments in this theme.
Numbers that matter. Revenue rose 10.6% year over year, while earnings growth declined 13.2%. EPR’s 91.9% gross margin, 54.33% operating margin and 35.63% net margin were among the strongest profitability figures in the group; return on equity was 11.32% and return on assets was 4.25%. Its trailing P/E of 18.18 and forward P/E of 19.27 were also more moderate than several peers.
Recent momentum.EPR has beaten estimates in all 7 of the last 7 reported quarters. In the July 29 quarter, EPS was $1.42 against an estimate of $1.31, an 8.4% beat. Analysts show 2 Buys, 8 Holds and 1 Sell, with a consensus score of 3.25 and an average target of $64.6818, reflecting strong execution but a cautious view of the specialty-property risk.
What they do.AGNC is a mortgage REIT that provides private capital to the U.S. housing market by investing in residential mortgage pass-through securities and collateralized mortgage obligations. The securities are backed by principal and interest guarantees from government-sponsored enterprises or government agencies, distinguishing AGNC from equity REITs that own physical properties.
Why it fits.AGNC is one of the most direct matches for the higher-yielding mortgage REIT segment of the theme. Its exposure is to residential mortgage securities rather than buildings, so investors should view the stock through the lens of interest-rate spreads, financing conditions and mortgage-market volatility instead of property-level rent growth.
Numbers that matter. Revenue growth was 546.1% year over year and earnings growth was 772.4%, though those figures reflect the distinct accounting and earnings volatility of a mortgage REIT. AGNC reported a 100% gross margin, a 95.61% operating margin and a 94.38% net margin, with return on equity of 19.8%. Its trailing P/E was 4.91 and forward P/E was 6.58, but the low multiples should not be compared directly with those of property-owning REITs.
Recent momentum.AGNC reported $0.40 of EPS for the July 20 quarter versus an estimate of $0.38, a 5.3% beat, but its seven-quarter record includes only 3 beats and a $0.17 loss against a $0.12 estimate in April. Analysts list 3 Buys and 9 Holds, with a consensus score of 3.5 and an average target of $11.0556. The stock offers strong theme exposure, but earnings variability remains central to the case.
Pick #2Premium members only
Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
The screen covers U.S.-listed REITs with market capitalizations above $500 million and evaluates each candidate using company descriptions, property exposure, profitability, revenue and earnings growth, valuation ratios, earnings surprises, analyst consensus and composite quality grades. Stocks are ordered primarily by their depth of exposure to the monthly dividend REIT theme, with business fundamentals used as the secondary differentiator. The ranking is refreshed monthly, so market capitalization, valuation, earnings records and analyst expectations can change between editions. The list is presented as a countdown from #7 to #1 rather than as a recommendation to buy or sell any individual security.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
